• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卓-艾综合征和神经肽分泌肿瘤对胃的影响。

The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.

作者信息

Pisegna J R

机构信息

Division of Gastroenterology and Hepatology (111C), VA Greater Los Angeles Health Care System, CURE: VA/UCLA Digestive Diseases Center, Building 115, Room 316, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA.

出版信息

Curr Gastroenterol Rep. 1999 Dec;1(6):511-7. doi: 10.1007/s11894-999-0012-8.

DOI:10.1007/s11894-999-0012-8
PMID:10980995
Abstract

Zollinger-Ellison syndrome (ZES) is caused by a tumor that secretes gastrin and is the most common of the malignant islet cell tumors. ZES leads to hypergastrinemia, which, in turn, causes an overproduction of gastric acid and results in complications of peptic ulcer disease. Of all the islet cell tumors, gastrinoma tumors have undergone the most extensive study, providing a model of tumor management. Increased awareness and improved biochemical and radiologic techniques mean that these disorders are being recognized in more patients. Advances in the management of gastric acid secretion and new localization methods have significantly reduced the morbidity and mortality associated with ZES. The use of intravenous proton pump inhibitors such as pantoprazole will make surgical and perioperative management more favorable for patients. Radiologic and nuclear medicine studies permit the detection of the majority of islet cell tumors and improve the ability for surgical resection. With the recent cloning of the gene for multiple endocrine neoplasia type I (MEN-I) and the recognition of tumor markers associated with the development of islet cell tumors, early detection of these tumors may someday be possible.

摘要

佐林格 - 埃利森综合征(ZES)由分泌胃泌素的肿瘤引起,是最常见的恶性胰岛细胞瘤。ZES导致高胃泌素血症,进而引起胃酸过度分泌,导致消化性溃疡病并发症。在所有胰岛细胞瘤中,胃泌素瘤的研究最为广泛,为肿瘤管理提供了一个模型。认识的提高以及生化和放射学技术的改进意味着更多患者被诊断出患有这些疾病。胃酸分泌管理的进展和新的定位方法显著降低了与ZES相关的发病率和死亡率。使用静脉注射质子泵抑制剂如泮托拉唑将使手术和围手术期管理对患者更为有利。放射学和核医学研究能够检测出大多数胰岛细胞瘤,并提高手术切除的成功率。随着最近多发性内分泌腺瘤I型(MEN - I)基因的克隆以及与胰岛细胞瘤发生相关的肿瘤标志物的发现,这些肿瘤的早期检测有朝一日可能成为现实。

相似文献

1
The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.卓-艾综合征和神经肽分泌肿瘤对胃的影响。
Curr Gastroenterol Rep. 1999 Dec;1(6):511-7. doi: 10.1007/s11894-999-0012-8.
2
All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.今日关于胃泌素瘤你需要了解的一切 | 胃泌素瘤与卓-艾综合征:全面更新
J Neuroendocrinol. 2023 Apr;35(4):e13267. doi: 10.1111/jne.13267. Epub 2023 Apr 11.
3
Zollinger-Ellison syndrome: recent advances and controversies.佐林格-埃利森综合征:最新进展与争议
Curr Opin Gastroenterol. 2013 Nov;29(6):650-61. doi: 10.1097/MOG.0b013e328365efb1.
4
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.胃泌素瘤和卓-艾综合征:新旧疗法管理之间的路线图。
World J Gastroenterol. 2021 Sep 21;27(35):5890-5907. doi: 10.3748/wjg.v27.i35.5890.
5
Zollinger-Ellison syndrome. Diagnosis and therapy.佐林格-埃利森综合征。诊断与治疗。
Minerva Med. 2005 Jun;96(3):187-206.
6
Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.质子泵抑制剂时代胃泌素瘤的诊断与治疗
Wien Klin Wochenschr. 2007;119(19-20):573-8. doi: 10.1007/s00508-007-0884-2.
7
Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.1型多发性内分泌肿瘤合并卓-艾综合征患者在所有胃泌素瘤手术切除后,II型胃类癌消退
World J Surg. 2004 Jul;28(7):652-8. doi: 10.1007/s00268-004-7345-0. Epub 2004 Jun 16.
8
Zollinger-Ellison syndrome: classical considerations and current controversies.佐林格-埃利森综合征:经典观点与当前争议。
Oncologist. 2014 Jan;19(1):44-50. doi: 10.1634/theoncologist.2013-0369. Epub 2013 Dec 6.
9
Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.病例报告:MEN-1 和 Zollinger-Ellison 综合征患者行最佳肿瘤细胞减灭术和奥曲肽治疗,疾病控制持久——超过十年的随访。
World J Surg Oncol. 2019 Dec 9;17(1):213. doi: 10.1186/s12957-019-1758-6.
10
Management of patients with Zollinger-Ellison syndrome.卓-艾综合征患者的管理
Annu Rev Med. 1995;46:395-411. doi: 10.1146/annurev.med.46.1.395.

引用本文的文献

1
Gastric Hypersecretory States: Investigation and Management.胃高分泌状态:调查与管理
Curr Treat Options Gastroenterol. 2015 Dec;13(4):386-97. doi: 10.1007/s11938-015-0065-8.
2
Duodenal bulb mucosa with hypertrophic gastric oxyntic heterotopia in patients with zollinger ellison syndrome.佐林格-埃利森综合征患者十二指肠球部黏膜伴肥厚性胃泌酸细胞异位
Diagn Ther Endosc. 2009;2009:298381. doi: 10.1155/2009/298381. Epub 2009 Jul 1.
3
Reflux laryngitis in a patient with Zollinger Ellison syndrome and the role of epidermal growth factor.

本文引用的文献

1
Surgery to cure the Zollinger-Ellison syndrome.治疗卓-艾综合征的手术。
N Engl J Med. 1999 Aug 26;341(9):635-44. doi: 10.1056/NEJM199908263410902.
2
Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.奥曲肽与α-干扰素联合治疗:对转移性内分泌胃肠胰腺肿瘤肿瘤生长的影响
Am J Gastroenterol. 1999 May;94(5):1381-7. doi: 10.1111/j.1572-0241.1999.01090.x.
3
The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR.
佐林格-埃利森综合征患者的反流性喉炎及表皮生长因子的作用
Dig Dis Sci. 2004 Apr;49(4):693-6. doi: 10.1023/b:ddas.0000026320.17006.14.
4
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.泮托拉唑:其药理特性及在酸相关性疾病管理中的治疗应用的最新进展。
Drugs. 2003;63(1):101-33. doi: 10.2165/00003495-200363010-00006.
5
Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition.医院环境中抑酸的药理学:聚焦于质子泵抑制
Crit Care Med. 2002 Jun;30(6 Suppl):S356-61. doi: 10.1097/00003246-200206001-00003.
垂体腺苷酸环化酶激活多肽1型受体(PAC1-R)在胃嗜铬样细胞上表达:免疫细胞化学和逆转录聚合酶链反应的证据。
Ann N Y Acad Sci. 1998 Dec 11;865:147-56. doi: 10.1111/j.1749-6632.1998.tb11173.x.
4
Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management.佐林格-埃利森综合征:发病机制、诊断与治疗
Am J Gastroenterol. 1997 Apr;92(4 Suppl):44S-48S; discussion 49S-50S.
5
Management of the Zollinger-Ellison syndrome in pregnancy.
Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):224-33. doi: 10.1016/s0002-9378(97)80041-5.
6
Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion.佐林格-埃利森综合征。胃酸分泌过多的识别与管理。
Drugs. 1996 Jul;52(1):33-44. doi: 10.2165/00003495-199652010-00003.
7
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.生长抑素类似物奥曲肽与转移性内分泌胃肠胰腺肿瘤的肿瘤生长抑制
Gut. 1996 Mar;38(3):430-8. doi: 10.1136/gut.38.3.430.
8
Zollinger-Ellison syndrome: diagnosis and management.佐林格-埃利森综合征:诊断与管理
Hosp Pract (1995). 1995 Nov 15;30(11):73-6, 79-80. doi: 10.1080/21548331.1995.11443290.
9
An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.人重组α干扰素在转移性胃泌素瘤患者中的评估。
Gastroenterology. 1993 Oct;105(4):1179-83. doi: 10.1016/0016-5085(93)90965-f.
10
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.奥曲肽作为一种抗肿瘤药物用于治疗功能性和非功能性神经内分泌肿瘤。
Cancer. 1993 Jul 1;72(1):244-8. doi: 10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q.